Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY009294-05
Application #
2162894
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1993-05-01
Project End
1997-12-31
Budget Start
1996-05-01
Budget End
1997-12-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Schepens Eye Research Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Theodoropoulou, Sofia; Kolovou, Paraskevi E; Morizane, Yuki et al. (2010) Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase. FASEB J 24:2620-30
van Ginkel, Paul R; Gee, Ricardo L; Shearer, Rebecca L et al. (2004) Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 64:128-34
Walker, Teresa M; Van Ginkel, Paul R; Gee, Ricardo L et al. (2002) Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 120:1719-25
Ohashi, Y (1999) Introduction: all for saving the visual axis. Chem Immunol 73:1-10
Ksander, B R; Geer, D C; Chen, P W et al. (1998) Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes. Curr Eye Res 17:165-73
Chen, P W; Murray, T G; Uno, T et al. (1997) Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease. Clin Exp Metastasis 15:509-18
Chen, P W; Murray, T G; Salgaller, M L et al. (1997) Expression of MAGE genes in ocular melanoma cell lines. J Immunother 20:265-75
Uno, T; Chen, P W; Murray, T G et al. (1997) Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector. Invest Ophthalmol Vis Sci 38:2531-9